Out of all the award shows in the award show season, the Critics Choice Awards might be the most underestimated. But, with ...
On October 14, 2024, the FDA approved a 320-mg single dose of bimekizumab-bkzx (Bimzelx; UCB) in a 2-mL prefilled syringe and autoinjector; both forms are now commercially available in the US.